Abel Hall LLC’s Alignment Healthcare ALHC Stock Holding History

Abel Hall LLC’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,287	Closed	-$243K	–	820
2025 Q4	$243K	Buy	+12,287	New	+$221K	0.06%	448

Other funds holding ALHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Abel Hall LLC's ALHC Position: Q1 2026 in Review

Abel Hall LLC sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 12,287 shares — an estimated $243K sold.

Abel Hall LLC first reported a position in ALHC in Q4 2025 and held it in 1 quarter. The position peaked at $243K in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

Abel Hall LLC reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
Abel Hall LLC sold 12,287 Alignment Healthcare shares in Q1 2026, an estimated $243K.
Abel Hall LLC first reported a position in Alignment Healthcare in Q4 2025 and held it in 1 quarter.
Abel Hall LLC's Alignment Healthcare position peaked at $243K in Q4 2025.
293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.